This system released over 70% of 5-ASA within 6–16 h at pH 7.0 and demonstrated therapeutic efficacy in a chronic colitis mouse model by significantly reducing the expression of IL-1β and TNF-α, as well as inflammatory markers such as MPO, H2O2, and MDA [120]. This evidence concerns the gene IL1B and Chronic colitis.